CRISPR Therapeutics
CRSP
CRSP
441 hedge funds and large institutions have $5.19B invested in CRISPR Therapeutics in 2021 Q1 according to their latest regulatory filings, with 107 funds opening new positions, 175 increasing their positions, 95 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
441
Holders Change
+31
Holders Change %
+7.56%
% of All Funds
7.77%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.09%
New
107
Increased
175
Reduced
95
Closed
71
Calls
$360M
Puts
$396M
Net Calls
-$35.8M
Net Calls Change
-$51.8M
Top Buyers
| 1 |
Two Sigma Investments
New York
|
$139M |
| 2 |
Two Sigma Advisers
New York
|
$125M |
| 3 |
Group One Trading
Chicago,
Illinois
|
$45.9M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$54.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
$33.6M |
